Sharon Barr, based in Boston, MA, US, is currently a EVP, Head of Biopharmaceuticals R&D at AstraZeneca, bringing experience from previous roles at AstraZeneca and Alexion Pharmaceuticals, Inc.. Sharon Barr holds a Stanford University School of Medicine. With a robust skill set that includes Drug Development, Biomarkers, Drug Discovery, Translational Research, Translational Medicine and more, Sharon Barr contributes valuable insights to the industry. Sharon Barr has 3 emails on RocketReach.